Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis

Completed · Phase 4

Conditions studied: Multiple Sclerosis

In brief

This study was designed to evaluate the safety and efficacy of Cesamet™ in controlling pain in subjects experiencing pain due to Multiple Sclerosis.

Key facts

Study ID

NCT00381264

Run by

NEMA Research, Inc.

People needed

23

Starts

2006-09-01

Expected to finish

2007-10-01

Last updated by the study team

2008-02-15

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients diagnosed with MS
• Chronic daily pain present for at least 2 months.
• On stable analgesic regimen for one month
• Baseline pain score greater than 40mm on a visual analog scale.

You may not qualify if…

• Hypersensitivity to compounds in study drug or similar drugs
• Pregnant or lactating females
• Drug or alcohol abuse
• Unstable medical condition

Where it is running

• South Florida Medical Research — Aventura, Florida, United States
• Sunrise Clinical Research, Inc. — Hollywood, Florida, United States
• Naples Anesthesia and Pain Associates — Naples, Florida, United States
• Lazlo Mate, MD — West Palm Beach, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.